Posttranslational modifications (PTMs) of ApoA-I alter its polarity and conformation that result in perturbed function [62] including impaired cholesterol efflux capacity of HDL in subjects with T2D [28]. Here, APOA1 is linked to type 2 diabetes mellitus.